(SB) Safe Bulkers - Overview
Exchange: NYSE •
Country: Monaco •
Currency: USD •
Type: Common Stock •
ISIN: MHY7388L1039
Stock: Bulk Carrier Fleets, Panamax, Kamsarmax, Post-Panamax, Capesize
Total Rating 46
Risk 40
Buy Signal 0.11
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.81% |
| Yield on Cost 5y | 10.75% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 51.8% |
| Payout Ratio | 111.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 33.2% |
| Relative Tail Risk | -6.10% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.50 |
| Alpha | 44.24 |
| Character TTM | |
|---|---|
| Beta | 0.819 |
| Beta Downside | 1.017 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.70% |
| CAGR/Max DD | 0.52 |
Description: SB Safe Bulkers December 29, 2025
Safe Bulkers, Inc. (NYSE:SB) operates a diversified dry-bulk fleet of 46 vessels-including 8 Panamax, 13 Kamsarmax, 17 post-Panamax, and 8 Capesize ships-totaling roughly 4.64 million deadweight tons, and transports coal, grain, and iron ore on a global basis. The company, incorporated in 2007 and headquartered in Monaco, is listed under the Marine Transportation sub-industry.
Key operational metrics that investors watch include the average vessel age of about 8 years (younger than the sector average of ~10 years) and a 2023 EBITDA of roughly $120 million, reflecting strong freight-rate environments for Capesize vessels (spot rates above $30,000/day in Q2 2024). Demand drivers remain robust, with Chinese steel production growth of ~4 % YoY and seasonal grain export peaks supporting higher utilization rates across the fleet.
For a deeper quantitative dive, you may find ValueRay’s analytics platform useful for benchmarking Safe Bulkers against peers and tracking real-time market dynamics.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 46.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 11.06 > 1.0 |
| NWC/Revenue: 36.56% < 20% (prev 9.58%; Δ 26.99% < -1%) |
| CFO/TA 0.07 > 3% & CFO 95.7m > Net Income 46.1m |
| Net Debt (401.0m) to EBITDA (140.3m): 2.86 < 3 |
| Current Ratio: 2.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (102.3m) vs 12m ago -4.17% < -2% |
| Gross Margin: 36.93% > 18% (prev 0.47%; Δ 3645 % > 0.5%) |
| Asset Turnover: 20.19% > 50% (prev 23.62%; Δ -3.43% > 0%) |
| Interest Coverage Ratio: 2.34 > 6 (EBITDA TTM 140.3m / Interest Expense TTM 34.3m) |
Altman Z'' 3.67
| A: 0.07 (Total Current Assets 159.0m - Total Current Liabilities 58.5m) / Total Assets 1.37b |
| B: 0.37 (Retained Earnings 507.3m / Total Assets 1.37b) |
| C: 0.06 (EBIT TTM 80.4m / Avg Total Assets 1.36b) |
| D: 1.51 (Book Value of Equity 826.3m / Total Liabilities 546.3m) |
| Altman-Z'' Score: 3.67 = AA |
Beneish M 1.00
| DSRI: 1.88 (Receivables 15.1m/9.28m, Revenue 274.7m/318.4m) |
| GMI: 1.28 (GM 36.93% / 47.17%) |
| AQI: 9.35 (AQ_t 0.07 / AQ_t-1 0.01) |
| SGI: 0.86 (Revenue 274.7m / 318.4m) |
| TATA: -0.04 (NI 46.1m - CFO 95.7m) / TA 1.37b) |
| Beneish M-Score: 2.77 (Cap -4..+1) = D |
What is the price of SB shares?
As of February 09, 2026, the stock is trading at USD 5.58 with a total of 787,414 shares traded.
Over the past week, the price has changed by -2.28%, over one month by +10.93%, over three months by +19.60% and over the past year by +62.17%.
Over the past week, the price has changed by -2.28%, over one month by +10.93%, over three months by +19.60% and over the past year by +62.17%.
Is SB a buy, sell or hold?
Safe Bulkers has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy SB.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.4 | -3.2% |
| Analysts Target Price | 5.4 | -3.2% |
| ValueRay Target Price | 7.2 | 28.3% |
SB Fundamental Data Overview February 02, 2026
P/E Trailing = 15.4324
P/E Forward = 2.0986
P/S = 2.1273
P/B = 0.696
P/EG = -1.07
Revenue TTM = 274.7m USD
EBIT TTM = 80.4m USD
EBITDA TTM = 140.3m USD
Long Term Debt = 481.8m USD (from longTermDebt, last quarter)
Short Term Debt = 34.5m USD (from shortTermDebt, last quarter)
Debt = 516.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 401.0m USD (from netDebt column, last quarter)
Enterprise Value = 985.3m USD (584.3m + Debt 516.3m - CCE 115.2m)
Interest Coverage Ratio = 2.34 (Ebit TTM 80.4m / Interest Expense TTM 34.3m)
EV/FCF = 18.02x (Enterprise Value 985.3m / FCF TTM 54.7m)
FCF Yield = 5.55% (FCF TTM 54.7m / Enterprise Value 985.3m)
FCF Margin = 19.91% (FCF TTM 54.7m / Revenue TTM 274.7m)
Net Margin = 16.78% (Net Income TTM 46.1m / Revenue TTM 274.7m)
Gross Margin = 36.93% ((Revenue TTM 274.7m - Cost of Revenue TTM 173.2m) / Revenue TTM)
Gross Margin QoQ = 39.40% (prev 27.66%)
Tobins Q-Ratio = 0.72 (Enterprise Value 985.3m / Total Assets 1.37b)
Interest Expense / Debt = 1.65% (Interest Expense 8.53m / Debt 516.3m)
Taxrate = 21.0% (US default 21%)
NOPAT = 63.5m (EBIT 80.4m * (1 - 21.00%))
Current Ratio = 2.72 (Total Current Assets 159.0m / Total Current Liabilities 58.5m)
Debt / Equity = 0.62 (Debt 516.3m / totalStockholderEquity, last quarter 826.3m)
Debt / EBITDA = 2.86 (Net Debt 401.0m / EBITDA 140.3m)
Debt / FCF = 7.33 (Net Debt 401.0m / FCF TTM 54.7m)
Total Stockholder Equity = 825.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.39% (Net Income 46.1m / Total Assets 1.37b)
RoE = 5.59% (Net Income TTM 46.1m / Total Stockholder Equity 825.1m)
RoCE = 6.15% (EBIT 80.4m / Capital Employed (Equity 825.1m + L.T.Debt 481.8m))
RoIC = 8.59% (NOPAT 63.5m / Invested Capital 739.2m)
WACC = 5.35% (E(584.3m)/V(1.10b) * Re(8.93%) + D(516.3m)/V(1.10b) * Rd(1.65%) * (1-Tc(0.21)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.25%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈54.7m ; Y1≈35.9m ; Y5≈16.4m
Fair Price DCF = 1.18 (EV 521.9m - Net Debt 401.0m = Equity 120.8m / Shares 102.3m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -77.09 | EPS CAGR: -52.64% | SUE: -4.0 | # QB: 0
Revenue Correlation: -62.12 | Revenue CAGR: -6.08% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.06 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.52 | Chg30d=-0.430 | Revisions Net=-1 | Growth EPS=+62.5% | Growth Revenue=+7.8%
P/E Forward = 2.0986
P/S = 2.1273
P/B = 0.696
P/EG = -1.07
Revenue TTM = 274.7m USD
EBIT TTM = 80.4m USD
EBITDA TTM = 140.3m USD
Long Term Debt = 481.8m USD (from longTermDebt, last quarter)
Short Term Debt = 34.5m USD (from shortTermDebt, last quarter)
Debt = 516.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 401.0m USD (from netDebt column, last quarter)
Enterprise Value = 985.3m USD (584.3m + Debt 516.3m - CCE 115.2m)
Interest Coverage Ratio = 2.34 (Ebit TTM 80.4m / Interest Expense TTM 34.3m)
EV/FCF = 18.02x (Enterprise Value 985.3m / FCF TTM 54.7m)
FCF Yield = 5.55% (FCF TTM 54.7m / Enterprise Value 985.3m)
FCF Margin = 19.91% (FCF TTM 54.7m / Revenue TTM 274.7m)
Net Margin = 16.78% (Net Income TTM 46.1m / Revenue TTM 274.7m)
Gross Margin = 36.93% ((Revenue TTM 274.7m - Cost of Revenue TTM 173.2m) / Revenue TTM)
Gross Margin QoQ = 39.40% (prev 27.66%)
Tobins Q-Ratio = 0.72 (Enterprise Value 985.3m / Total Assets 1.37b)
Interest Expense / Debt = 1.65% (Interest Expense 8.53m / Debt 516.3m)
Taxrate = 21.0% (US default 21%)
NOPAT = 63.5m (EBIT 80.4m * (1 - 21.00%))
Current Ratio = 2.72 (Total Current Assets 159.0m / Total Current Liabilities 58.5m)
Debt / Equity = 0.62 (Debt 516.3m / totalStockholderEquity, last quarter 826.3m)
Debt / EBITDA = 2.86 (Net Debt 401.0m / EBITDA 140.3m)
Debt / FCF = 7.33 (Net Debt 401.0m / FCF TTM 54.7m)
Total Stockholder Equity = 825.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.39% (Net Income 46.1m / Total Assets 1.37b)
RoE = 5.59% (Net Income TTM 46.1m / Total Stockholder Equity 825.1m)
RoCE = 6.15% (EBIT 80.4m / Capital Employed (Equity 825.1m + L.T.Debt 481.8m))
RoIC = 8.59% (NOPAT 63.5m / Invested Capital 739.2m)
WACC = 5.35% (E(584.3m)/V(1.10b) * Re(8.93%) + D(516.3m)/V(1.10b) * Rd(1.65%) * (1-Tc(0.21)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.25%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈54.7m ; Y1≈35.9m ; Y5≈16.4m
Fair Price DCF = 1.18 (EV 521.9m - Net Debt 401.0m = Equity 120.8m / Shares 102.3m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -77.09 | EPS CAGR: -52.64% | SUE: -4.0 | # QB: 0
Revenue Correlation: -62.12 | Revenue CAGR: -6.08% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.06 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.52 | Chg30d=-0.430 | Revisions Net=-1 | Growth EPS=+62.5% | Growth Revenue=+7.8%